Smith & Nephew

SN.: 1,654.50 -1.00 (-0.06%) delayed: 15 Nov 2019, 18:30

Trade now

Smith & Nephew Fundamentals

Share Price Information

Name Smith & Nephew
Epic SN.
Sector Medical Equipment
ISIN GB0009223206
Activites Smith & Nephew plc is a portfolio medical technology business that exists to restore people's bodies, and their self-belief. Smith & Nephew has leadership positions in Orthopaedics, Advanced Wound Management and Sports Medicine, more than 16,000 employees and a presence in more than 100 countries. Annual sales in 2018 were $4.9 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN).
Index FTSE 100

Key numbers

Latest Share price (p) 1,654.50 Net gearing (%) 34.99
Market capitalisation (£m) 14,485.12 Gross gearing (%) 39.52
Shares in issue (m) 874.97 Debt ratio 26.08
P/E ratio 21.78 Debt-to-equity ratio 0.54
Total dividends per share (p) 36.00 Assets / equity ratio 1.65
Dividend yield (%) 1.71 Price to book value 2.97
Dividend cover 2.09 ROCE (%) 11.84
Earning per share (p) 76.00 EPS growth (%) -13.44
52-week high / low (p) 1,998.00 / 1,376.00 DPS growth (%) 2.86

Results at a glance

Date Type Turnover (£m) Profit (£m) Basic EPS Currency
31 Dec 2018 Full Year 4,904 663 76.00 USD
31 Dec 2017 Full Year 4,765 767 87.80 USD
31 Dec 2016 Full Year 4,669 784 88.10 USD

Dividend history

Period Ex-date Pay-date Net dividend Currency Total for year
H1 Dividend 03 Oct 2019 30 Oct 2019 14.40 USX 0.00
H2 Dividend 04 Apr 2019 08 May 2019 22.00 USX 36.00
H1 Dividend 04 Oct 2018 31 Oct 2018 14.00 USX 0.00
H2 Dividend 05 Apr 2018 09 May 2018 22.70 USX 35.00
H1 Dividend 05 Oct 2017 01 Nov 2017 12.30 USX 0.00
H2 Dividend 30 Mar 2017 10 May 2017 18.50 USX 30.80
H1 Dividend 06 Oct 2016 25 Oct 2016 12.30 USX 0.00
H2 Dividend 21 Apr 2016 11 May 2016 19.00 USX 30.80
H1 Dividend 08 Oct 2015 27 Oct 2015 11.80 USX 0.00
H2 Dividend 16 Apr 2015 06 May 2015 18.60 USX 29.60

Contact details

Company name Smith & Nephew
Address 15 Adam Street, London WC2N 6LA.
Telephone +44 (0)20 7401 7646
Website http://www.smith-nephew.com/

Advisors

Company's broker JPMorgan Cazenove
Company's joint broker UBS Investment Bank
NOMAD n/a
Registrar Equiniti
Auditors Ernst & Young LLP
Solicitors Ashurst LLP

Directors

Appointed Director Position
07 May 2018 Namal Nawana Chief Executive Officer
01 Mar 2017 Graham Timothy Baker Chief Financial Officer
04 Dec 2013 Roberto Quarta Non-Executive Chairman
01 Dec 2014 Vinita Bali Non-Executive Director
12 Apr 2012 Virginia Hilda Brunette Maxwell Bottomley Non-Executive Director
01 Mar 2018 Roland Daniel Diggelmann Non-Executive Director
01 Jan 2015 Erik Engstrom Non-Executive Director
01 Sep 2015 Robin Anthony David Freestone Non-Executive Director
01 Oct 2017 Marc Ellis Owen Non-Executive Director
18 Sep 2017 Angela Susan Risley Non-Executive Director

Company financials

Assets (£m) 2018 2017 2016
Reporting date 31 Dec 2018 31 Dec 2017 31 Dec 2016
Tangible assets 1,062 1,049 982
Intangible asssets and goodwill 3,547 3,742 3,599
Investments and other non-current assets 373 344 234
Total non-current assets 4,982 5,135 4,815
Inventory / work in progress 1,395 1,304 1,244
Trade and other receivables 1,317 1,258 1,185
Cash and equivalents 365 169 100
Other current assets and asset held for resale 0 0 0
Total of all assets 8,059 7,866 7,344
Liabilities (£m) 2018 2017 2016
Short term liabilities 1,465 1,346 1,348
Long term liabilities 1,720 1,876 2,038
Other liabilites / pension etc 0 0 0
Total of all liabilities 3,185 3,222 3,386
Net assets (£m) 2018 2017 2016
Net assets 4,874 4,644 3,958
Equity (£m) 2018 2017 2016
Share capital 177 178 180
Minority interests 0 0 0
Retained earnings 4,625 4,329 3,970
Share premium account 608 605 600
Other equity -536 -468 -792
Total equity 4,874 4,644 3,958
Cash Flow (£m) 2018 2017 2016
Cash from operating activities 931 1,090 849
Cashflow before financing 553 547 466
Increase / decrease in Cash 182 113 -63
Income (£m) 2018 2017 2016
Turnover 4,904 4,765 4,669
Cost of sales 1,298 1,248 1,272
Gross profit 3,606 3,517 3,397
Operating profit 863 934 801
Pre-tax profit 781 879 1,062
Profit / loss for the year 663 767 784